Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Roth

Showing results (591-600 of 611) with videos related to

Pageof 62
Sort By:
International Journal of Spine Surgery|July 4, 2024
Impact of Targeted Systemic Therapy and Radiotherapy on Patients Undergoing Spine Surgery for Metastatic Renal Cell CarcinomaHani Chanbour, Jeffrey W Chen, Gabriel A Bendfeldt, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 22, 2019
GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosisYingze Zhang, Mao Jiang, Mehdi Nouraie, et al.
Ultrasound in Medicine & Biology|May 28, 2025
Feasibility of Contrast-Enhanced Ultrasound Fusion With Pretreatment MR/CT for Recurrence Detection in Renal Cell Carcinoma Patients During Post-Ablation SurveillanceAylin Tahmasebi, Tania Siu Xiao, Corinne E Wessner, et al.
Metabolic Engineering|March 18, 2022
Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteinsMagdalena Malm, Chih-Chung Kuo, Mona Moradi Barzadd, et al.
The Journal of Investigative Dermatology|February 26, 2019
Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic MelanomaMeredith McKean, Junna Oba, Junsheng Ma, et al.
Biofabrication|August 27, 2024
Complex<i>in vitro</i>models positioned for impact to drug testing in pharma: a reviewSerah Kang, Eugene C Chen, Helen Cifuentes, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Design of Selective sPLA<sub>2</sub>-X Inhibitor (-)-2-{2-[Carbamoyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]pyridine-2-yl}propanoic AcidFabrizio Giordanetto, Laurent Knerr, Peter Nordberg, et al.
Radiology|October 17, 2023
Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter TrialEsika Savsani, Colette M Shaw, Flemming Forsberg, et al.
British Journal of Haematology|November 7, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational studyF Huguet, A Guerci-Bresler, G Roth-Guepin, et al.
Blood|June 22, 2016
Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutationsAbner Louissaint, Kristian T Schafernak, Julia T Geyer, et al.
Pageof 62

Showing results (591-600 of 611) with videos related to

Sort By:
Pageof 62
International Journal of Spine Surgery|July 4, 2024
Impact of Targeted Systemic Therapy and Radiotherapy on Patients Undergoing Spine Surgery for Metastatic Renal Cell CarcinomaHani Chanbour, Jeffrey W Chen, Gabriel A Bendfeldt, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 22, 2019
GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosisYingze Zhang, Mao Jiang, Mehdi Nouraie, et al.
Ultrasound in Medicine & Biology|May 28, 2025
Feasibility of Contrast-Enhanced Ultrasound Fusion With Pretreatment MR/CT for Recurrence Detection in Renal Cell Carcinoma Patients During Post-Ablation SurveillanceAylin Tahmasebi, Tania Siu Xiao, Corinne E Wessner, et al.
Metabolic Engineering|March 18, 2022
Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteinsMagdalena Malm, Chih-Chung Kuo, Mona Moradi Barzadd, et al.
The Journal of Investigative Dermatology|February 26, 2019
Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic MelanomaMeredith McKean, Junna Oba, Junsheng Ma, et al.
Biofabrication|August 27, 2024
Complex<i>in vitro</i>models positioned for impact to drug testing in pharma: a reviewSerah Kang, Eugene C Chen, Helen Cifuentes, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Design of Selective sPLA<sub>2</sub>-X Inhibitor (-)-2-{2-[Carbamoyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]pyridine-2-yl}propanoic AcidFabrizio Giordanetto, Laurent Knerr, Peter Nordberg, et al.
Radiology|October 17, 2023
Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter TrialEsika Savsani, Colette M Shaw, Flemming Forsberg, et al.
British Journal of Haematology|November 7, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational studyF Huguet, A Guerci-Bresler, G Roth-Guepin, et al.
Blood|June 22, 2016
Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutationsAbner Louissaint, Kristian T Schafernak, Julia T Geyer, et al.
Pageof 62